NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Ind-Swift Laboratories Limited (NSE: INDSWFTLAB)

 
INDSWFTLAB Technical Analysis
5
As on 26th Oct 2021 INDSWFTLAB Share Price closed @ 59.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 77.99 & Strong Sell for SHORT-TERM with Stoploss of 66.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

INDSWFTLAB Share Price

Open 58.00 Change Price %
High 60.50 1 Day 1.30 2.25
Low 55.15 1 Week -2.30 -3.74
Close 59.20 1 Month -4.65 -7.28
Volume 111090 1 Year 7.35 14.18
52 Week High 127.45 | 52 Week Low 46.85
 
NSE INDIA Most Active Stocks
IDEA 10.40 0.00%
PNB 45.85 2.12%
BANKBARODA 99.90 3.52%
TATAPOWER 225.30 5.48%
YESBANK 13.45 0.75%
IDFCFIRSTB 52.85 7.09%
JPPOWER 4.75 1.06%
BHEL 71.65 4.29%
CANBK 193.35 -4.26%
TATAMOTORS 508.65 5.99%
 
NSE INDIA Top Gainers Stocks
WILLAMAGOR 24.00 20.00%
PNC 45.10 19.95%
PNC 45.10 19.95%
PNC 45.10 19.95%
PNC 45.10 19.95%
KEI 965.35 19.14%
KEI 965.35 19.14%
KEI 965.35 19.14%
KEI 965.35 19.14%
KEI 965.35 19.14%
 
NSE INDIA Top Losers Stocks
GPIL 361.05 -72.50%
JIKIND 0.45 -10.00%
VARDHACRLC 73.70 -8.16%
ORTINLAB 32.65 -6.85%
MRPL 51.65 -6.68%
GRINFRA 1997.15 -6.11%
RPSGVENT 797.20 -5.43%
TARAPUR 3.70 -5.13%
BPL 100.95 -4.99%
BPL 100.95 -4.99%
 
 
INDSWFTLAB
Daily Charts
INDSWFTLAB
Intraday Charts
Whats New @
Bazaartrend
INDSWFTLAB
Free Analysis
 
INDSWFTLAB Important Levels Intraday
RESISTANCE69.51
RESISTANCE66.20
RESISTANCE64.16
RESISTANCE62.12
SUPPORT56.28
SUPPORT54.24
SUPPORT52.20
SUPPORT48.89
 
INDSWFTLAB Target for Month October
4th UP TARGET82.03
3rd UP TARGET76.34
2nd UP TARGET72.83
1st UP TARGET69.31
1st DOWN TARGET59.29
2nd DOWN TARGET55.77
3rd DOWN TARGET52.26
4th DOWN TARGET46.57
 
INDSWFTLAB Weekly Target
4th UP TARGET69.46
3rd UP TARGET66.15
2nd UP TARGET64.11
1st UP TARGET62.07
1st DOWN TARGET56.23
2nd DOWN TARGET54.19
3rd DOWN TARGET52.15
4th DOWN TARGET48.84
 
INDSWFTLAB Target for Year 2021
4th UP TARGET173.82
3rd UP TARGET138.04
2nd UP TARGET115.92
1st UP TARGET93.81
1st DOWN TARGET30.69
2nd DOWN TARGET8.58
3rd DOWN TARGET-13.54
4th DOWN TARGET-49.32
 
 
INDSWFTLAB Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 50.49 Sideways
MFI (14) MFI is 46.81 Sideways
CCI (20) CCI is 13.92 Sideways
WILLIAM %R (14) William %R is -28.07 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 15.06
10 Day Avg Volume Traded 60.16 % More then 10 Day Average Volume
 
INDSWFTLAB Other Details
Segment EQ
Market Capital 3489071104.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
INDSWFTLAB Address
INDSWFTLAB
 
INDSWFTLAB Latest News
 
Your Comments and Response on Ind-Swift Laboratories Limited
 
INDSWFTLAB Business Profile
Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. It provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India. Address: Shivalik Enclave, Manimajra, India, 160101
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service